Clinical Trial - Stem Cell and Growth Factor - Osteoarthritis Knee

The Foundation for Sports Medicine and Arthritis Research is running a clinical trial to test a device named Amniotic Tissue Allograft to treat OA of knee. One important mechanism of action may be stimulation of the synovial cells to increase production of endogenous hyaluronic acid (HA). A second mechanism may be the increase in the anabolic factors and a decrease in degenerative factors in the joint.

The device is Amniotic Tissue Allograft, the drug is Saline, and HA.

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 88 participants
Allocation: Randomized
Intervention Model: Sequential Assignment
Masking: Single (Participant)
Primary Purpose: Treatment
Official Title: Short-Term Changes in Knee Synovial Fluid Composition Following Intraarticular Implantation of Amniotic Tissue Allograft
Actual Study Start Date : January 4, 2018
Estimated Primary Completion Date : December 2018
Estimated Study Completion Date : December 2018

For enrollment please visit www.clinicaltrials.gov.

 

* The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.